ATE135217T1 - Pharmazeutische zusammensetzungen zur aids- behandlung - Google Patents

Pharmazeutische zusammensetzungen zur aids- behandlung

Info

Publication number
ATE135217T1
ATE135217T1 AT91917237T AT91917237T ATE135217T1 AT E135217 T1 ATE135217 T1 AT E135217T1 AT 91917237 T AT91917237 T AT 91917237T AT 91917237 T AT91917237 T AT 91917237T AT E135217 T1 ATE135217 T1 AT E135217T1
Authority
AT
Austria
Prior art keywords
image
pharmaceutical compositions
bri
aids treatment
aliphatic
Prior art date
Application number
AT91917237T
Other languages
English (en)
Inventor
Stanislaw R Burzynski
Original Assignee
Stanislaw R Burzynski
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stanislaw R Burzynski filed Critical Stanislaw R Burzynski
Application granted granted Critical
Publication of ATE135217T1 publication Critical patent/ATE135217T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT91917237T 1990-09-04 1991-08-21 Pharmazeutische zusammensetzungen zur aids- behandlung ATE135217T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/577,464 US5089508A (en) 1990-09-04 1990-09-04 Methods for treating aids

Publications (1)

Publication Number Publication Date
ATE135217T1 true ATE135217T1 (de) 1996-03-15

Family

ID=24308852

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91917237T ATE135217T1 (de) 1990-09-04 1991-08-21 Pharmazeutische zusammensetzungen zur aids- behandlung

Country Status (11)

Country Link
US (1) US5089508A (de)
EP (1) EP0500905B1 (de)
AT (1) ATE135217T1 (de)
AU (1) AU638869B2 (de)
DE (1) DE69117923T2 (de)
DK (1) DK0500905T3 (de)
ES (1) ES2084181T3 (de)
GR (1) GR3019970T3 (de)
SG (1) SG81889A1 (de)
WO (1) WO1992004027A1 (de)
ZA (1) ZA916977B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5244922A (en) * 1990-09-04 1993-09-14 Burzynski Stanislaw R Methods for treating viral infections
EP0527241B1 (de) * 1991-07-15 1994-03-16 Artesan Pharma Gesellschaft mit beschränkter Haftung Verwendung der Ascorbinsäure zur Zubereitung von Arzneimitteln zur Anwendung im Genitalbereich
US5646182A (en) * 1992-06-15 1997-07-08 Burzynski; Stanislaw R. Methods for treating autoimmune diseases
EP0906088B1 (de) * 1996-05-14 2005-11-23 BURZYNSKI, Stanislaw R. Liposomale antineoplaston therapie mit bemerkenswert verbesserter antineoplastischer aktivität
US6127419A (en) * 1998-11-23 2000-10-03 Burzynski; Stanislaw R. Phenylacetic acid compositions for treating or preventing atherosclerosis and restenosis

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4470970A (en) * 1981-07-02 1984-09-11 Burzynski Stanislaw R Purified antineoplaston fractions and methods of treating neoplastic disease
US4558057A (en) * 1981-12-15 1985-12-10 Burzynski Stanislaw R Purified antineoplaston fractions and methods of treating neoplastic disease
US4427684A (en) * 1982-09-24 1984-01-24 Ores Richard O Treatment and prevention of infection with herpes simplex and related viruses
EP0216555B1 (de) * 1985-09-11 1992-09-02 Btg International Limited Verwendung von Dioxopiperidin-Derivaten zur Behandlung von Anxietas, zur Herabsetzung von chronischen abnormal hohen Gehirn-Spiegeln Serotonins oder 5-Hydroxy-Indolessigsäure und zur Behandlung von bakteriellen oder viralen Infektionen
US4705796A (en) * 1986-08-25 1987-11-10 Stereochemical Genetics, Inc. Use of 3-N-phenylacetylamino-2,6-piperidinedione for treatment of neuropsychiatric disorders
DE3814549A1 (de) * 1987-10-30 1989-05-18 Bayer Ag N-substituierte derivate von 1-desoxynojirimycin und 1-desoxymannonojirimycin, verfahren zu deren herstellung und deren verwendung in arzneimitteln

Also Published As

Publication number Publication date
SG81889A1 (en) 2001-07-24
US5089508A (en) 1992-02-18
DK0500905T3 (da) 1996-08-05
GR3019970T3 (en) 1996-08-31
DE69117923D1 (de) 1996-04-18
ZA916977B (en) 1992-06-24
AU8539791A (en) 1992-03-30
EP0500905A1 (de) 1992-09-02
DE69117923T2 (de) 1996-08-01
WO1992004027A1 (en) 1992-03-19
EP0500905B1 (de) 1996-03-13
ES2084181T3 (es) 1996-05-01
AU638869B2 (en) 1993-07-08

Similar Documents

Publication Publication Date Title
ATE231519T1 (de) Dinukleotide zur verwendung in der behandlung von lungenkrankheiten
ES2165969T3 (es) Compuestos nitrogenados aromaticos condensados 5,5 aril-sustituidos como agentes antiinflamatorios.
SE8601103D0 (sv) Neue, schwefelhaltige 5-substituierte benzimidazol-derivate und verfahren zu ihrer herstellung
DE69327642D1 (de) Verfahren zur behandlung von viralen infectionen
DE69727956D1 (de) Pharmazeutische zubereitungen zur verminderung von atmungsdepressionen
ES2141957T3 (es) Uso de raloxifeno y sus analogos para la produccion de un medicamento para el tratamiento de enfermedades virales.
PT100415A (pt) Novas morfolinas de accao farmaceutica, e processo para a sua preparacao
DE69117923D1 (de) Pharmazeutische zusammensetzungen zur aids-behandlung
ES2082882T3 (es) Procedimiento para la fabricacion de derivados de acidos-3-amino-2-(het)aroil-acrilicos.
BR9712033A (pt) Composição farmacêutica para tratamento de doenças virais.
ATE134363T1 (de) N-((4,5-dihydroxy- und 4,5,8-trihydroxy-9,10- dihydro-9,10-dioxo-2-anthracen- yl)carbonyl)aminosäure zur therapie osteoartikulärer leiden
KR930702978A (ko) 인식력 장애의 치료
ATE162714T1 (de) Zusammensetzungen und verfahren zur behandlung von autoimmunkrankheiten
MY133438A (en) Morpholinobenzamide salts
BR9306870A (pt) Derivados farmacologicamente ativos de (aminometila terciária) - benzenometanol
ATE37370T1 (de) Triazolderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen.
ES8307778A1 (es) Procedimiento para preparar difenilbutil-1-piperazinocarboxilatos.
ES2121071T3 (es) Compuestos de oxazolidina y su empleo como medicamentos.
ES2005778A6 (es) Procedimiento para la obtencion de derivados de diisobutilxantina.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee